2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors
about
A physiological role of the adenosine A3 receptor: sustained cardioprotectionThe A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channelEmerging adenosine receptor agonistsThe A3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteinsPharmacological characterization of novel A3 adenosine receptor-selective antagonistsCardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptorModulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsDesign and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells.A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.Adenosine and ischemic preconditioning.Activation of A3 adenosine receptors on human eosinophils elevates intracellular calciumThe role of activated adenosine receptors in degranulation of human LAD2 mast cells.A3-adenosine receptors: design of selective ligands and therapeutic prospectsDiscovery of New Human A(2A) Adenosine Receptor Agonists: Design, Synthesis, and Binding Mode of Truncated 2-Hexynyl-4'-thioadenosine.The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells.Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious ratsTargeting the inflammasome and adenosine type-3 receptors improves outcome of antibiotic therapy in murine anthraxN6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.Adenosine receptor agonists: from basic medicinal chemistry to clinical development.Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.Partial agonists for A(3) adenosine receptors.Season primes the brain in an arctic hibernator to facilitate entrance into torpor mediated by adenosine A(1) receptors.Controlling murine and rat chronic pain through A3 adenosine receptor activationInduction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptorsExploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effectsMethanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure.Activation of Phosphoinositide Breakdown and Elevation of Intracellular Calcium in a Rat RBL-2H3 Mast Cell Line by Adenosine Analogs: Involvement of A(3)-Adenosine Receptors?Chapter 13. A3 Adenosine Receptors.RADIOLABELING AND EFFICIENT SYNTHESIS OF TRITIATED 2-CHLORO-N(6)-(3-IODOBENZYL)ADENOSINE-5'-N-METHYLURON-AMIDE, A POTENT, SELECTIVE A3 ADENOSINE RECEPTOR AGONIST.Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
P2860
Q24650457-68078581-B7CB-4CF7-B858-789A6F524D78Q24651378-909DD254-0E55-4215-8643-6F0ADC599BCEQ28249111-F21BEFC9-5328-45E8-8D09-C8C68E98E5A5Q28344385-0255FB2D-D6FD-4FF6-8506-DEA372ED57BAQ28379206-B16C6846-866A-4915-B244-B8C3EDDAEE8EQ28771714-1A6065DA-6648-40E3-94FB-ACF2CF723ED6Q30424626-1E658698-3FDC-4EB8-BB05-34142E2588AFQ30486707-4EFAEE4F-E2DD-4061-934F-F1F075157FD9Q33554208-7C7B87F1-91D8-4407-A9A9-75888D516919Q33754565-732668DC-BF60-4F54-96F1-EDEC2DB40D18Q33797566-D5EAFF9F-93AE-4716-84C1-397D818CBD6CQ33801903-0CB1D054-79D3-495D-ABC0-BC97356FF6D5Q33802595-F82CE86A-A057-4BD3-BC90-499B55E19451Q34123216-44B480B3-C78D-406E-BBE7-F2226310F00CQ34204046-EA8F9AEB-50D1-44FB-96C5-E7D1D2778E80Q34536571-5C79C2D3-EAE4-4E61-960C-C57D649912DDQ34590372-AFE40DFF-2786-4B14-9E1B-8CBA8504AB73Q34871163-CC23B072-4FEF-4918-BFFE-D32ED3756B2AQ35033714-21DA060B-4A68-4DE4-8870-C9803325B144Q35124859-3435716E-A776-44F4-BD29-75039918003CQ35235736-12E7824C-3F12-4A06-96FA-5D0AB2A49E95Q35602688-43D009B9-5D59-4E8E-B2AB-03F27BC5FE88Q35698610-5A11A991-71B4-407F-B81E-984882803C2BQ35741734-4EA506EA-0F1F-4B8E-BAD2-EDEC9E3BECB3Q35743739-8966085D-F769-45C5-AA08-B298F999A942Q35887493-E59620DC-1B31-4560-9AFA-153FC3B62398Q35913037-0989E53C-6830-4A46-BB91-B496614F60D4Q36008898-DE0BF612-740B-47EA-96E1-7299EC4AAD7CQ36146803-2E4F1402-9383-46C0-BABF-0B7D921E3CCEQ36243301-7A5E3FA4-E860-47AE-814B-2858E1FD3057Q36277783-A61AC287-BAA8-44F9-93CB-01BEBDF4A070Q36286344-79CD4612-72F1-41B5-93F5-542D38C850EAQ36294009-C317D3D6-BBC1-4689-8898-FF8748BFCDEEQ36311423-44A1A582-5FD1-4703-B1CD-6C142B345F96Q36316924-68FB3EE4-95F8-4B3A-88F2-FD350B703AF7Q36317172-C9F93BE1-FEA4-453A-A2EC-A41B4A94A919Q36330660-55EF5F78-F775-48CB-996E-85D0263DA581Q36342540-747E5B1A-47B6-432A-A291-A54E514E0DFBQ36610751-CF82BB91-093E-419E-B69E-A26C6BC1CB9EQ36627486-E3EFF012-D4B4-48CC-ACB3-4D9D9E127E6C
P2860
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@ast
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@en
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@nl
type
label
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@ast
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@en
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@nl
prefLabel
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@ast
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@en
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@nl
P2093
P2860
P356
P1476
2-Substitution of N6-benzylade ...... ity for A3 adenosine receptors
@en
P2093
P2860
P304
P356
10.1021/JM00047A018
P407
P577
1994-10-14T00:00:00Z